Enhancing hypertension awareness and management in the elderly: Lessons learned from the Airdrie Community Hypertension Awareness and Management Program (A-CHAMP)

Canadian Journal of Cardiology

Volumn 24, Issue 7, 2008, Pages 561-567

  Jones, Charlotte ^a,f   Simpson, Scot H ^a   Mitchell, Diana ^b   Haggarty, Susan ^a   Campbell, Norman ^a   Then, Karen ^b   Lewanczuk, Richard Z ^b   Sebaldt, Rolf J ^a   Farrell, Barbara ^c   Dolovich, Lisa ^c   Kaczorowski, Janusz ^d   Chambers, Larry W ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f Health Sciences Centre Calgary   (Canada)

Author keywords

Blood pressure; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COMMUNITY CARE; CONTROLLED STUDY; DRUG DOSE INCREASE; ELDERLY CARE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH EDUCATION; HEALTH EDUCATOR; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PHARMACIST; PRIMARY PREVENTION; PUBLIC HEALTH SERVICE; SYSTOLIC BLOOD PRESSURE; ATTITUDE TO HEALTH; AWARENESS; BLOOD PRESSURE; CANADA; COMPARATIVE STUDY; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HOSPITALIZATION; METHODOLOGY; OUTCOME ASSESSMENT; PHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; RURAL POPULATION; STANDARD;

AGED; ALBERTA; AWARENESS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PERSONNEL; HUMANS; HYPERTENSION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREVALENCE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RURAL POPULATION; SEVERITY OF ILLNESS INDEX;

EID: 47549114536     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(08)70634-2     Document Type: Article

References (31)

1. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
2. Hemmelgarn BR, Zarnke KB, Campbell NR, et al; Canadian Hypertension Education Program, Evidence-Based Recommendations Task Force. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol 2004;20:31-40.
3. Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ 1992;146:1997-2005.
4. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557-62.
5. Kannel WB. Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA 1996;275:1571-6.
6. O'Donnell C, Kannel W. Cardiovascular risks of hypertension: Lessons from observational studies. J Hypertens Suppl 1998;16:S3-7.
7. Schappert SM. National ambulatory medical care survey, 1991 summary. Vital Health Stat 1994;13:1-110.
8. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-10.
9. World Health Organization. The World Health Report 2002. Geneva: World Health Organization, 2002.
10. Joffres MR, Ghadirian P, Fodor JG, Petrasovits A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997;10:1097-102.
11. Joffres MR, Hamet P, MacLean DR, L'Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertension. 2001;14:1099-105.
12. Klawansky S. Treatment of hypertension. In: Frazier HS, Mosteller F, eds. Medicine Worth Paying for: Assessing Medical Innovations. Cambridge: Harvard University Press, 1995:139-54.
13. McLean DL, Simpson SH, McAlister FA, Tsuyuki RT. Treatment and blood pressure control in 47,964 people with diabetes and hypertension: A systematic review of observational studies. Can J Cardiol 2006;22:855-60.
14. Hertert S, Bailey G, Cottinghan V, et al. Community volunteers as recruitment staff in a clinical trial: The systolic hypertension in the elderly program (SHEP) experience. Control Clin Trials 1996;17:23-32. (Erratum in 1996;17:271).
15. Chambers LW, Kaczorowski J, Dolovich L, et al. A community-based program for cardiovascular health awareness. Can J Public Health 2005;96:294-8.
16. Pora VV, Farrell B, Dolovich L, Kaczorowski J, Chambers LW; CHAP working group. Promoting cardiovascular health among older adults: A pilot study with community pharmacists. Can Pharm J 2005;138:50-5.
17. Khan NA, McAlister FA, Lewanczuk RZ, et al; Canadian Hypertension Education Program. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - therapy. Can J Cardiol 2005;21:657-72.
18. PHARMALearn. (Version current at April 30, 2008).
19. British Hypertension Society. (Version current at April 30, 2008).
20. Canadian Hypertension Society. (Version current at April 30, 2008).
21. Mattu GS, Perry TL Jr, Wright JM. Comparison of the oscillometric blood pressure monitor (BPM-100β) with the auscultatory mercury sphygmomanometer. Blood Press Monit 2001;6:153-9.
22. Wright JM, Mattu GS, Perry Jr TL, et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit 2001;6:161-5.
23. Fig.P Software Corporation. (Version current at April 30, 2008).
24. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.
25. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
26. Johnson JA, Vermeulen SU. Epidemiological trends of diabetes in Alberta. Alberta Diabetes Atlas, 2007: Institute of Health Economics: 11-24.
27. Karwalajtys T, Kaczorowski J, Chambers LW, et al. A randomized trial of mail vs. telephone invitation to a community-based cardiovascular health awareness program for older family practice patients [ISRCTN61739603]. BMC Fam Pract 2005;6:35-42.
28. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 2002;162:1149-55.
29. Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: The Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus). Am J Med 2004;116:130-3.
30. Khan NA, McAlister FA, Rabkin SW, et al; Canadian Hypertension Education Program. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - therapy. Can J Cardiol 2006;22:583-93.
31. Simpson SH, Johnson JA, Biggs C, et al; Study of Cardiovascular Risk Intervention by Pharmacist Investigators. Practice-based research: Lessons from community pharmacist participants. Pharmacotherapy 2001;21:731-9.